An observational study in Knee Osteoarthritis, sponsored by Össur Iceland ehf. Recruiting at 1 site in Sweden. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-10-19.
Sponsored by Össur Iceland ehf (part of Embla Medical hf.) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Osteoarthritis, Knee with a site in Sweden — 12 open to participants now, 19 under way, none of them phase 3. Osteoarthritis, Knee · Sweden.
Among the 54 studies in Osteoarthritis, Knee with a site in Sweden, this one is the 4th largest by planned enrollment of the 16 observational ones that give a count, is one of 3 that started in 2020, is one of 16 observational ones, reaches primary completion later than 17 of the 18 other live ones, and was the 30th registered.
3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.
Browse Osteoarthritis, Knee studies →12 of the 54 studies in Osteoarthritis, Knee with a site in Sweden are open now. Recruiting first, the newest first:
Vastra Gotaland Region · Sites in Sweden
Ages 30+
Vastra Gotaland Region · Sites in Sweden
Ages 18+
Uppsala University · Sites in Sweden
Ages 18–100
Region Skane · Sites in Sweden
Ages 25+
Danderyd Hospital · Sites in Sweden
Ages 18+
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 18 Years to 100 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 6 · Phase 3 7
First in 2005; this study’s year is marked. 3 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,500 is above the median of 100 across 486 observational studies indexed under Osteoarthritis, Knee.
Median enrollment 175 across the 38 interventional studies, 246 across the 16 observational. Of the 30 that completed or were terminated, 8 (27%) have results posted.
This tab as a report to print or save as PDF → With an account.
18 of 54 have an industry lead sponsor. The 10 most frequent:
This study is registered under Össur Iceland ehf, one of the names counted as Embla Medical hf.. Under that name alone:
Össur Iceland ehf is the lead sponsor of 24 studies on the registry; 5 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 8 (80%) have results posted.
Embla Medical hf. has 1 study filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
5 of the studies in Osteoarthritis, Knee with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05584410Vastra Gotaland RegionDigitalization of Osteoarthritis Care | 2026-12-31 |
| NCT07212920Vastra Gotaland RegionValidity and Reliability of Video-Based Functional Physiotherapy Assessment of Subacute Knee Injuries | 2026-12-31 |
| NCT06459700Lund UniversityEffect of Probiotic Supplements on Osteoarthritis Outcomes | 2027-04-30 |
| NCT07875647Mälardalen UniversityPerson-Centred Digital Rehabilitation for Knee Osteoarthritis | 2027-09 |
| NCT07383740Vastra Gotaland RegionTest-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis | 2027-09-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 54 studies in Osteoarthritis, Knee with a site in Sweden, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study is a non-controlled retro- and prospective multi center patient registry study.
Subjects will be given a study ID number assigned at first brace fitting after consenting to partake. Participants will be asked to fill in a questionnaire either in electronic or paper version at first fitting. Additional follow up questionnaires will be implemented at 4 weeks, 6 months and 1 year post initial brace fitting. After that period patients will be contacted every year, until brace termination/ knee surgery or death.
This is a noninterventional registry study pertaining to knee OA braces. There are no comparative devices or treatments. Subjects are expected to follow the recommendations of the brace subscriber and other health care professionals at any time independent of their continuation within the registry.
Subjects will be enrolled at the clinic where their brace was prescribed or at the site where the brace was fitted.
There is no formal end date for this data registry. A revisit to this protocol may be motivated after 5 years, to assess if longer follow up is required.
For individual participants follow up will continue with annual questionnaires as long as the brace is in use. The questionnaires will be administered either through mail with a paper version, or through a link to an electronical version (ePRO). There is also a possibility of administrating the questionnaires as a phone guided interview, if that is a mean that serves the patient or clinics better. The planned follow-ups are at 4 weeks, 6 months, 1 year from brace prescription and then annually as long as participants are disposed as "ongoing" in the registry.
The questionnaires contains question about pain, function, medication, general brace use and quality of life question.
Subjects are patients that have been prescribed knee braces for treatment of knee OA. The brace prescription is independent of the registry, i.e. no one is prescribed a brace because of the registry or for the purpose of this data collection per se
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All patients, at listed investigational sites, that get prescription for a knee orthosis indicated for Knee OA symptomatic treatment, get an invite to partake in the evaluation registry.
Proportion of patients that are using the braces
brace usage, days per week
Time frame: 6 months follow up
Change in Pain status compared to baseline
Knee injury and Osteoarthritis Outcome Score (KOOS)-12
Time frame: 6 months follow up
Change in Mobility compared to baseline
KOOS-12
Time frame: 6 months follow up
Proportion of patients that are still using the braces
brace usage, days per week
Time frame: 1 year follow up
Change in Pain status compared to baseline
KOOS-12
Time frame: 1 year follow up
Change in Mobility compared to baseline
KOOS-12
Time frame: 1 year follow up
Sick leave after receiving the braces
Proportion of sick leave
Time frame: 6 months follow up
Sick leave after receiving the braces
Proportion of sick leave
Time frame: 1 year follow up
Changes in reported quality of life
KOOS-12
Time frame: 6 months follow up
Changes in reported quality of life
KOOS-12
Time frame: 1 year follow up
Changes in QALY's
EQ-5D-5L
Time frame: 6 months follow up
Changes in QALY's
EQ-5D-5L
Time frame: 1 year follow up
The patients' satisfaction of the value/effectiveness of the brace
Numeric Rating Scale (NRS) for satisfaction (0-10)
Time frame: 6 months follow up
The patients' satisfaction of the value/effectiveness of the brace
NRS for satisfaction (0-10)
Time frame: 1 year follow up
Plan to share: No
No publications or documents are linked to this record.
Started Sep 2020 (actual). Primary completion is estimated for Dec 2030, 123 months after the start.
Of 220 observational studies under Osteoarthritis, Knee, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 61. This study's planned 123 months is above that.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.